Explore 3 Stock Ideas & Industry Insights Download Free Report

American Vanguard Corporation

Basic Materials US AVD

2.575USD
0.03(0.98%)

Last update at 2026-06-23T20:00:00Z

Day Range

2.412.63
LowHigh

52 Week Range

2.055.92
LowHigh

Fundamentals

  • Previous Close 2.55
  • Market Cap78.77M
  • Volume189145
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA22.80M
  • Revenue TTM515.11M
  • Revenue Per Share TTM18.12
  • Gross Profit TTM 147.56M
  • Diluted EPS TTM-1.63

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -47.20300M -120.45800M 10.30M 35.97M 27.14M
Minority interest - - - - -
Net income -49.88200M -126.34000M 7.52M 27.40M 18.59M
Selling general administrative 98.51M 115.52M 111.15M 53.46M 61.69M
Selling and marketing expenses - 4.11M 5.74M 101.48M 91.93M
Gross profit 135.44M 120.32M 179.16M 241.35M 213.24M
Reconciled depreciation 18.74M 22.32M 21.89M 22.14M 22.23M
Ebit 6.58M -31.97900M 22.94M 40.65M 30.95M
Ebitda 25.32M -9.43100M 44.72M 62.79M 53.68M
Depreciation and amortization 18.74M 22.55M 21.78M 22.14M 22.73M
Non operating income net other - - - - -
Operating income 6.58M -101.55500M 23.30M 40.65M 30.95M
Other operating expenses 508.53M 648.86M 556.08M 568.96M 526.10M
Interest expense 18.58M 16.78M 12.64M 3.95M 3.69M
Tax provision 2.68M 5.88M 0.44M 8.56M 8.17M
Interest income 0.11M 18.90M 0.37M 4.69M 4.48M
Net interest income -18.47000M -16.54700M -9.98000M -3.95400M -3.68700M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 2.68M 5.88M 2.78M 8.56M 8.17M
Total revenue 515.11M 547.31M 579.37M 609.62M 556.87M
Total operating expenses 128.86M 221.87M 155.87M 200.70M 182.47M
Cost of revenue 379.68M 426.99M 400.21M 368.26M 343.63M
Total other income expense net -53.78300M -18.90300M -12.99800M -4.68600M -3.80500M
Discontinued operations - - - - -
Net income from continuing ops -49.88200M -126.34000M 4.44M 27.40M 18.98M
Net income applicable to common shares -49.88200M -126.34000M 7.52M 27.40M 18.59M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 596.54M 636.72M 767.55M 726.31M 694.16M
Intangible assets 138.75M 150.50M 172.51M 184.66M 197.84M
Earning assets - - - - -
Other current assets 14.27M 7.62M 6.26M 15.85M 12.49M
Total liab 404.14M 403.61M 397.54M 356.33M 321.42M
Total stockholder equity 192.40M 233.11M 370.01M 369.98M 372.74M
Deferred long term liab - - - 14.60M 20.01M
Other current liab 113.58M 101.44M 84.43M 81.72M 87.80M
Common stock 3.49M 3.48M 3.47M 3.44M 3.43M
Capital stock 3.49M 3.48M 3.47M 3.44M 3.43M
Retained earnings 155.00M 204.88M 332.90M 328.75M 304.38M
Other liab - - - 18.76M 25.34M
Good will 0.00000M 19.70M 51.20M 47.01M 46.26M
Other assets 17.44M 9.73M 0.00000M 10.91M 28.78M
Cash 12.43M 12.51M 11.42M 20.33M 16.29M
Cash and equivalents 12.43M 12.51M 11.42M 20.33M 16.29M
Total current liabilities 209.45M 232.35M 230.50M 266.60M 223.06M
Current deferred revenue - 52.67M 65.56M 110.60M 63.06M
Net debt 178.96M 155.29M 150.68M 55.92M 61.79M
Short term debt 5.76M 6.14M 6.08M 5.28M 5.06M
Short long term debt - - - - -
Short long term debt total 191.39M 167.81M 162.09M 76.25M 78.08M
Other stockholder equity 45.91M 43.48M 39.61M 49.97M 78.71M
Property plant equipment 69.83M 77.90M 96.98M 70.91M 91.50M
Total current assets 370.52M 378.89M 432.02M 388.57M 342.00M
Long term investments - - - - -
Net tangible assets - - - 138.31M 128.64M
Short term investments - - -0.42500M - -
Net receivables 167.79M 179.47M 194.79M 168.20M 158.92M
Long term debt 174.00M 147.33M 138.90M 51.48M 52.24M
Inventory 176.03M 179.29M 219.55M 184.19M 154.31M
Accounts payable 87.50M 69.16M 68.83M 69.00M 67.14M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -12.00000M -18.72900M -5.96300M -12.18200M -13.78400M
Additional paid in capital - - - - -
Common stock total equity - - - 3.44M 3.43M
Preferred stock total equity - - - - -
Retained earnings total equity - - - 328.75M 304.38M
Treasury stock - - - -55.66200M -22.73900M
Accumulated amortization - - - - -
Non currrent assets other 14.80M 8.48M 14.84M 10.77M 16.29M
Deferred long term asset charges - - - - -
Non current assets total 226.01M 257.83M 335.53M 337.75M 352.16M
Capital lease obligations 17.39M 20.48M 23.19M 24.77M 25.84M
Long term debt total 174.00M 147.33M 138.90M 51.48M 52.24M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -6.62300M -13.64000M -14.47000M -20.04200M
Change to liabilities - - - -5.56500M 36.70M
Total cashflows from investing activities -6.62300M -6.62300M -17.01700M -14.47000M -20.04200M
Net borrowings 26.67M 8.43M 86.60M -1.00000M -55.56900M
Total cash from financing activities 4.54M 4.54M 66.74M -38.26000M -65.87100M
Change to operating activities - - - -6.76200M 18.80M
Net income -126.34000M -126.34000M 7.52M 27.40M 18.59M
Change in cash 1.10M 1.10M -8.91200M 4.04M 0.36M
Begin period cash flow 11.42M 11.42M 20.33M 16.29M 15.92M
End period cash flow 12.51M 12.51M 11.42M 20.33M 16.29M
Total cash from operating activities 3.92M 3.92M -58.74800M 57.10M 87.32M
Issuance of capital stock - - - - 0.74M
Depreciation 22.55M 22.32M 21.78M 22.14M 22.23M
Other cashflows from investing activities 0.66M 1.06M 0.24M -1.20900M -10.00000M
Dividends paid 2.51M 2.51M 3.38M -2.78700M -2.38200M
Change to inventory 6.29M 35.18M -27.31500M -29.56000M 8.13M
Change to account receivables 7.69M 3.71M -16.71000M -6.44700M -24.34700M
Sale purchase of stock -1.43200M -1.43200M -17.50600M -36.06900M -7.53400M
Other cashflows from financing activities -16.65400M 0.05M 1.03M 254.60M -1.12900M
Change to netincome - - - 2.43M 6.22M
Capital expenditures 7.28M 7.69M 12.06M 14.55M 10.04M
Change receivables - - - -6.44700M -24.34700M
Cash flows other operating - - - 46.42M 18.48M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - 4.38M 0.45M
Change in working capital -20.21900M 48.01M -87.94400M 2.96M 36.69M
Stock based compensation 4.41M 4.41M 6.14M 5.68M 6.88M
Other non cash items 122.07M 55.62M 3.98M 5.63M 5.85M
Free cash flow -3.35600M -3.76500M -70.81200M 42.55M 77.28M

Peer Comparison

Sector: Basic Materials Industry: Agricultural Inputs

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AVD
American Vanguard Corporation
0.03 0.98% 2.58 - 15.08 0.15 0.41 0.50 10.49
CTVA
Corteva Inc
0.25 0.32% 79.11 45.91 22.22 3.11 2.23 2.99 16.92
NTR
Nutrien Ltd
-0.71 1.14% 61.54 54.62 15.27 1.14 1.17 1.64 10.45
CF
CF Industries Holdings Inc
-1.43 1.38% 102.17 12.92 13.97 2.63 3.85 2.86 6.18
MOS
The Mosaic Company
-0.75 3.41% 21.25 9.17 11.07 0.78 0.98 1.00 5.38

Reports Covered

Stock Research & News

Profile

American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets synthetic, biological, and biorational products for agricultural, commercial, and consumer uses in the United States and internationally. The company synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection, such as insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms. It distributes its products through national distribution companies, buying groups, or co-operatives, as well as through sales offices, wholly owned distributors, sales force executives, and sales agents. American Vanguard Corporation was incorporated in 1969 and is headquartered in Newport Beach, California.

American Vanguard Corporation

4695 MacArthur Court, Newport Beach, CA, United States, 92660

Key Executives

Name Title Year Born
Mr. Eric G. Wintemute Chairman & CEO 1956
Mr. David T. Johnson VP, CFO & Treasurer 1957
Dr. Ulrich G. Trogele Ph.D. COO & Exec. VP 1958
Mr. Timothy J. Donnelly Esq. Gen. Counsel, Chief Admin. Officer & Sec. 1960
Mr. Peter E. Eilers Managing Director of AMVAC Netherlands BV 1964
Mr. Anthony Scott Hendrix Sr. VP of Crop Sales for U.S. & Canada 1971
Mr. William A. Kuser Director of Investor Relations & Corp. Communications NA
Mr. Robert F. Gilbane Pres of Gemchem Inc 1951
James Thompson Director of Bus. Devel., Portfolio Management Biologicals & Non-Crop NA
Mr. Douglas A. Kaye III Chairman & CEO 1969

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions